| Type | MGI:General | Description | enhanced susceptibility to Leishmania major at lower physiologically relevant doses larger lesions after L. major infection, 4X the size in controls at 6 week higher parasite burdens at site of infection, peaking at 6 weeks parasite level in spleens reaches 44X that of controls at 7 weeks but decreases after 8 weeks and infection is resolved by 14 weeks |
